Lv36
230 积分 2026-05-11 加入
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study
24天前
已完结
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
1个月前
已完结
Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population
1个月前
已完结
Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma
1个月前
已完结
Age of asthma onset does not impact the response to omalizumab
1个月前
已完结
Real-world effectiveness of dupilumab in patients with asthma
1个月前
已完结
Prospective direct comparison of biologic treatments for severe eosinophilic asthma
1个月前
已完结
Mepolizumab in children and adolescents with severe eosinophilic asthma not eligible for omalizumab: a single Center experience
1个月前
已完结
Effectiveness of omalizumab across different dosing regimens in patients with moderate-to-severe allergic asthma
1个月前
已完结
Anti-IL-5 and anti-IL-5R biologics for severe asthma. Are there any differences in their effects?
1个月前
已完结
皖公网安备34019202002308
